AR118705A2 - FACTOR VII POLIPEPTIDE TO TREAT DISEASES, METHOD FOR PREPARING IT AND COMPOSITION CONTAINING IT - Google Patents

FACTOR VII POLIPEPTIDE TO TREAT DISEASES, METHOD FOR PREPARING IT AND COMPOSITION CONTAINING IT

Info

Publication number
AR118705A2
AR118705A2 ARP200101074A ARP200101074A AR118705A2 AR 118705 A2 AR118705 A2 AR 118705A2 AR P200101074 A ARP200101074 A AR P200101074A AR P200101074 A ARP200101074 A AR P200101074A AR 118705 A2 AR118705 A2 AR 118705A2
Authority
AR
Argentina
Prior art keywords
factor vii
polipeptide
preparing
composition containing
treat diseases
Prior art date
Application number
ARP200101074A
Other languages
Spanish (es)
Inventor
Terry Hermiston
Maxine Bauzon
Original Assignee
Coagulant Therapeutics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coagulant Therapeutics Corp filed Critical Coagulant Therapeutics Corp
Publication of AR118705A2 publication Critical patent/AR118705A2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se divulgan polipéptidos del Factor VII de acción corta. Es deseable acortar la semivida para el tratamiento de hemorragias agudas y trastornos similares. La modificación de la sialilación y/o glucosilación del Factor VII y variantes del mismo produjeron péptidos útiles en el tratamiento de afecciones de hemorragia aguda.Short acting Factor VII polypeptides are disclosed. Shortening the half-life is desirable for the treatment of acute bleeding and similar disorders. Modification of the sialylation and / or glycosylation of Factor VII and variants thereof produced peptides useful in the treatment of acute bleeding conditions.

ARP200101074A 2012-12-24 2020-04-16 FACTOR VII POLIPEPTIDE TO TREAT DISEASES, METHOD FOR PREPARING IT AND COMPOSITION CONTAINING IT AR118705A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261745674P 2012-12-24 2012-12-24

Publications (1)

Publication Number Publication Date
AR118705A2 true AR118705A2 (en) 2021-10-27

Family

ID=56117356

Family Applications (4)

Application Number Title Priority Date Filing Date
ARP130105071A AR094317A1 (en) 2012-12-24 2013-12-27 SHORT ACTION FACTOR VII POLIPEPTIDES
ARP200101072A AR118703A2 (en) 2012-12-24 2020-04-16 FACTOR VII POLIPEPTIDE TO TREAT A DISEASE
ARP200101074A AR118705A2 (en) 2012-12-24 2020-04-16 FACTOR VII POLIPEPTIDE TO TREAT DISEASES, METHOD FOR PREPARING IT AND COMPOSITION CONTAINING IT
ARP200101073A AR118704A2 (en) 2012-12-24 2020-04-16 FACTOR VII POLIPEPTIDE TO TREAT DISEASES

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ARP130105071A AR094317A1 (en) 2012-12-24 2013-12-27 SHORT ACTION FACTOR VII POLIPEPTIDES
ARP200101072A AR118703A2 (en) 2012-12-24 2020-04-16 FACTOR VII POLIPEPTIDE TO TREAT A DISEASE

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP200101073A AR118704A2 (en) 2012-12-24 2020-04-16 FACTOR VII POLIPEPTIDE TO TREAT DISEASES

Country Status (1)

Country Link
AR (4) AR094317A1 (en)

Also Published As

Publication number Publication date
AR118703A2 (en) 2021-10-27
AR118704A2 (en) 2021-10-27
AR094317A1 (en) 2015-07-29

Similar Documents

Publication Publication Date Title
CO2017011851A2 (en) Novel compounds
PH12016501139B1 (en) Bicyclic heterocycle compounds and their uses in therapy
UA117096C2 (en) Polypeptides binding to human complement c5
EA201591367A1 (en) CONNECTIONS RESORTS FOR DERMATOLOGICAL APPLICATIONS
ECSP15001882A (en) NOVEL 5-AMINOTETRAHYDROQUINOLIN-2-CARBOXYLIC ACIDS AND THEIR USE
CU20150095A7 (en) FUSIONATED PYRIMIDINES REPLACED WITH TRIFLUOROMETILO
WO2013151665A3 (en) Modified polynucleotides for the production of proteins associated with human disease
BR112014029967A2 (en) low-dust animal beds and methods for making them
EA201591839A1 (en) THERAPEUTIC PEPTIDES
CO6950477A2 (en) Apoptosis inducing agents that can be used to treat cancer and autoimmune and immune diseases
EA201790032A1 (en) BICYCLICALLY SUBSTITUTED URACILES AND THEIR APPLICATION
EA201992707A1 (en) COMPOUNDS AND THEIR APPLICATIONS FOR HEMOGLOBIN MODULATION
CR20120508A (en) ROBO1-Fc FUSION PROTEIN AND ITS USE IN TUMOR TREATMENT
MD20150109A2 (en) Mitochondrial proteins constructs and uses thereof
BR112015024860A2 (en) vaccines comprising leishmania polypeptides for the treatment and diagnosis of leishmaniasis
EA201590568A1 (en) COMPOSITIONS CONTAINING PLANT EXTRACTS
MX2016000294A (en) Pharmaceutical composition for a sustained release of lanreotide.
UY35745A (en) SUBSTITUTED DERIVATIVES OF PHENYLALANINE
MX2021002985A (en) Short-acting factor vii polypeptides.
BR112015028737A2 (en) methods for hormone production and / or purification
MX2016006544A (en) Withanolides useful for the treatment of neurodegenerative diseases.
AR118705A2 (en) FACTOR VII POLIPEPTIDE TO TREAT DISEASES, METHOD FOR PREPARING IT AND COMPOSITION CONTAINING IT
MX2016005645A (en) Topical pharmaceutical composition of acitretin.
EA201890209A1 (en) COMPOSITION CONTAINING TANINS
CL2016001054A1 (en) Compounds for the treatment of diabetes and complications of diseases derived from it